Funding Support and Author Disclosures Dr Bhatt has received consulting fees from Sanofi Pasteur, Verve Therapeutics, and Clarivate; and has been supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL007604. Dr Ibrahim has received honoraria from Cytokinetics, Medtronic, Novartis, and Roche; and has been a consultant for Cytokinetics. Dr Vaduganathan has received research grant support or served on advisory boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals, Relypsa, and Roche Diagnostics; has had speaker engagements with Novartis and Roche Diagnostics; and has participated on clinical endpoint committees for studies sponsored by Galmed and Novartis.